Navigation Links
Islanders and Tourists with Brain Cancer to Benefit from Hawaiian Center's Installment of Elekta's Leksell Gamma Knife Perfexion

HONOLULU and ATLANTA, Aug. 16 /PRNewswire/ -- Surrounded by thousands of square miles of ocean, Gamma Knife Center of the Pacific is the only Gamma Knife® center in Hawaii. Since 1998, Gamma Knife Center of the Pacific has treated more than 1,300 patients, offering residents a convenient treatment option and tourists a way to combine needed therapy with the pleasures of a paradise.

In August, the radiosurgery center will retire its first Leksell Gamma Knife system and begin operating Elekta's latest generation radiosurgery system, Leksell Gamma Knife® Perfexion. Gamma Knife radiosurgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease, which is cancer that has travelled to the brain from elsewhere in the body. With pinpoint accuracy, the system delivers up to thousands of low-intensity radiation beams to one or more targets in a single session. Perfexion provides even greater speed and ease of use than previous models.

"Perfexion is a much faster, more efficient machine to treat multiple metastases in a single visit," says Maurice Nicholson, M.D., neurosurgeon and the center's medical director. "This is important because the pendulum is swinging toward treating with stereotactic radiosurgery [SRS] rather than whole brain radiation therapy [WBRT]. Studies have shown that there is decreased mental function at four months in a higher percentage of WBRT patients. Perfexion will be good for the patients and good for physicians."

More than one-third of the 140 patients who come to Gamma Knife Center of the Pacific each year have brain metastases. "The numbers are rising due to advances in tumor imaging and better screening—which result in earlier detection and diagnosis," says Dr. Nicholson. "With new treatments, people who are diagnosed with cancer live longer; therefore, there is a greater chance of developing metastases."

With Perfexion, the center's staff of eight neurosurgeons, five radiation oncologists and one physicist is well equipped to handle increasing demand. "With the new system, we could easily double the number of patients we're treating."

For "medical tourism," few venues beat Hawaii

Pragmatic patients with cancer are increasingly combining needed therapy with vacations in popular destinations, a trend known as medical tourism. Gamma Knife surgery is usually a single-day procedure with no specific convalescence associated with it, making this therapy ideal compared to radiation therapy or open surgery in which the combination of treatment and recovery may entail weeks or months. Gamma Knife Center of the Pacific has been the focus of this activity for years, treating patients from Australia, New Zealand, Samoa, Guam, Taipei and Canada.

"Our location in Honolulu, just 10 minutes from Waikiki, presents a great opportunity for people seeking Gamma Knife treatment in close proximity to one of the world's most famous vacation destinations," says Sean Nicholson, the center's CFO. "The Gamma Knife Center of the Pacific always strives to provide access for patients outside of Hawaii. Our staff works closely with patients to schedule and coordinate appointments, assist with travel arrangements and lodging, provide cost estimates and work with insurance companies to secure payment."

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
3. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
4. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
5. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
6. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
7. One Shot of Gene Therapy Spreads Through Brain in Animal Study
8. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
9. Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord
10. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
11. PET Scans Show Gene Therapy Normalizes Brain Function in Parkinsons Patients
Post Your Comments:
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):